獸醫內分泌市場規模、佔有率和成長分析:按產品類型、治療領域、動物類型、最終用戶和地區分類 - 產業預測,2026-2033 年
市場調查報告書
商品編碼
2003604

獸醫內分泌市場規模、佔有率和成長分析:按產品類型、治療領域、動物類型、最終用戶和地區分類 - 產業預測,2026-2033 年

Veterinary Endocrinology Market Size, Share, and Growth Analysis, By Product Category, By Therapeutic Area, By Animal Type, By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球獸醫內分泌市場價值 4.7 億美元,預計將從 2025 年的 5.0243 億美元成長到 2033 年的 8.5684 億美元,在預測期(2026-2033 年)內以 6.9% 的複合年成長率成長。

全球獸醫內分泌市場是一個多元化的市場,涵蓋診斷、治療、醫療設備和服務,旨在解決伴侶動物和家畜的荷爾蒙失調問題。其成長主要受慢性內分泌疾病日益普遍的推動,而寵物「人性化」和診斷技術的進步進一步促進了這一成長。糖尿病和甲狀腺機能低下症等疾病對動物福利和獸醫醫療保健成本造成了重大影響。從有限的檢查室檢測轉向照護現場(PoC)解決方案,包括連續血糖監測和標靶荷爾蒙療法,正是這一發展趨勢的標誌。此外,技術整合正在簡化診斷流程並促進專業服務的發展,從而提高治療依從性。人工智慧驅動的診斷等創新技術提高了效率,並透過使獸醫院能夠更有效地處理複雜病例,為檢測開發商和獸醫教育機構拓展了市場機會。

全球獸醫內分泌市場促進因素

除了伴侶動物飼養趨勢之外,飼主日益重視改善寵物健康也顯著提升了對獸醫內分泌解決方案的需求。隨著越來越多的寵物飼主尋求定期獸醫檢查,內分泌疾病的識別和治療也變得越來越普遍,這增加了對專業診斷、荷爾蒙療法和持續監測服務的需求。由於人們越來越關注提高寵物的生活品質,獸醫正在實施更全面的診斷通訊協定和長期治療策略,從而推動了內分泌相關產品和服務在各類動物醫院、醫院和實驗室網路中的穩步普及。

全球獸醫內分泌市場面臨的限制因素

全球獸醫內分泌市場面臨嚴峻挑戰,主要原因是受過內分泌學訓練的獸醫短缺。這種短缺限制了臨床醫生識別複雜荷爾蒙失調的能力,也限制了他們有效利用先進診斷技術。因此,常見症狀可能被誤診為其他疾病,導致內分泌相關檢查和治療的轉診量下降。此外,專家的短缺也限制了全科獸醫的教育機會,進而減緩了創新診斷工具的普及,並限制了對專業檢測和設備的需求,尤其是在專家諮詢和培訓資源匱乏的地區。

全球獸醫內分泌市場趨勢

全球獸醫內分泌市場正呈現出精準診斷的顯著趨勢,獸醫診所擴大採用先進的診斷平台和檢測方法。這一轉變提高了內分泌疾病檢測的準確性,從而能夠更早地進行干預並制定更個性化的治療方案。臨床醫生更傾向於選擇能夠提供明確治療指南的高特異性檢測方法,這促進了實驗室與獸醫院之間的合作。此外,服務整合以及與技術供應商的合作正在簡化樣本檢體流程和報告流程。這些強調標準化通訊協定的進步,提高了寵物飼主和獸醫對診斷價值的認知,最終推動了對各種動物物種可靠內分泌檢測的需求。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球獸醫內分泌市場規模:依產品類型

  • 診斷試劑盒
  • 治療藥物
  • 實驗室設備

全球獸醫內分泌市場規模:依治療領域分類

  • 甲狀腺疾病
  • 腎上腺皮質功能亢進
  • 糖尿病管理
  • 愛迪生氏症

全球獸醫內分泌市場規模:依動物類型分類

  • 伴侶動物
  • 家畜
    • 家禽

全球獸醫內分泌市場規模:依最終用戶分類

  • 動物醫院
  • 診斷與研究實驗室
  • 學術機構

全球獸醫內分泌市場規模:依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要企業2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要企業簡介

  • Idexx Laboratories
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health
  • VetMed Labs
  • Vetoquinol
  • Neogen Corporation
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • Virbac
  • Elanco
  • Dechra Pharmaceuticals
  • Veterinary Laboratories Agency
  • Triveritas
  • Heska Corporation
  • PetDx
  • 3M Animal Care
  • Spectrum Labs
  • Animal Health International
  • Animal Metabolomics

結論與建議

簡介目錄
Product Code: SQMIG35A3302

Global Veterinary Endocrinology Market size was valued at USD 470.0 Million in 2024 and is poised to grow from USD 502.43 Million in 2025 to USD 856.84 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global veterinary endocrinology market is a multifaceted landscape encompassing diagnostics, therapeutics, devices, and services aimed at addressing hormonal disorders in both companion animals and livestock. Its growth is primarily fueled by the increasing prevalence of chronic endocrine diseases, driven further by pet humanization and advancements in diagnostic capabilities. Conditions like diabetes mellitus and hypothyroidism significantly impact animal welfare and veterinary expenses. Transitioning from limited lab tests to point-of-care solutions, including continuous glucose monitors and targeted hormone therapies, exemplifies this evolution. Additionally, the integration of technology streamlines diagnosis and fosters specialized services, enhancing treatment adherence. Innovations such as AI-driven diagnostics improve efficiency, allowing practices to handle complex cases more effectively, expanding market opportunities for test developers and veterinary training providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Endocrinology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Endocrinology Market Segments Analysis

Global veterinary endocrinology market is segmented by product category, therapeutic area, animal type, end-user and region. Based on product category, the market is segmented into Diagnostic Kits, Therapeutic Drugs and Lab-based Instruments. Based on therapeutic area, the market is segmented into Thyroid Disorders, Hyperadrenocorticism, Diabetes Mellitus Management and Addison's Disease. Based on animal type, the market is segmented into Companion Animals and Livestock. Based on end-user, the market is segmented into Veterinary Hospitals, Diagnostic & Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Endocrinology Market

The growing trend of companion animal ownership, coupled with the increased commitment from caregivers to enhance their pets' healthcare, has significantly boosted the demand for veterinary endocrinology solutions. As more pet owners seek regular veterinary check-ups, the identification and management of endocrine disorders have become more prevalent, driving the need for specialized diagnostics, hormonal therapies, and ongoing monitoring services. With a heightened focus on improving the quality of life for pets, veterinarians are implementing more thorough diagnostic protocols and long-term treatment strategies, resulting in a consistent uptake of endocrinology products and services across various veterinary practices, hospitals, and laboratory networks.

Restraints in the Global Veterinary Endocrinology Market

The Global Veterinary Endocrinology market faces significant challenges due to the insufficient number of veterinarians trained in endocrinology. This shortage restricts the ability of clinicians to identify intricate hormonal disorders and utilize advanced diagnostic procedures effectively. As a result, common symptoms may be misattributed to other ailments, leading to a decrease in referrals for endocrinology-related testing and treatment. Furthermore, the lack of specialists limits the educational opportunities for general practitioners, which in turn delays the adoption of innovative diagnostic tools and restricts the demand for specialized assays and devices, particularly in areas with limited access to expert consultation and training resources.

Market Trends of the Global Veterinary Endocrinology Market

The Global Veterinary Endocrinology market is witnessing a significant trend towards the adoption of precision diagnostics, as veterinary practices increasingly implement advanced diagnostic platforms and assays. This shift enhances the detection of endocrine disorders, allowing for earlier interventions and more personalized treatment plans. Clinicians are favoring tests that provide higher specificity and clearer treatment pathways, which encourages collaboration between laboratories and animal health clinics. Additionally, the consolidation of services and partnerships with technology providers is streamlining sample workflows and reporting processes. With an emphasis on standardized protocols, these developments are elevating the perceived diagnostic value among pet owners and practitioners, ultimately driving demand for reliable endocrinology testing across diverse animal species.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Veterinary Endocrinology Market Size by Product Category & CAGR (2026-2033)

  • Market Overview
  • Diagnostic Kits
  • Therapeutic Drugs
  • Lab-based Instruments

Global Veterinary Endocrinology Market Size by Therapeutic Area & CAGR (2026-2033)

  • Market Overview
  • Thyroid Disorders
  • Hyperadrenocorticism
  • Diabetes Mellitus Management
  • Addison's Disease

Global Veterinary Endocrinology Market Size by Animal Type & CAGR (2026-2033)

  • Market Overview
  • Companion Animals
    • Dogs
    • Cats
    • Horses
  • Livestock
    • Cattle
    • Swine
    • Poultry

Global Veterinary Endocrinology Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Veterinary Hospitals
  • Diagnostic & Research Laboratories
  • Academic Institutes

Global Veterinary Endocrinology Market Size & CAGR (2026-2033)

  • North America (Product Category, Therapeutic Area, Animal Type, End-User)
    • US
    • Canada
  • Europe (Product Category, Therapeutic Area, Animal Type, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Category, Therapeutic Area, Animal Type, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Category, Therapeutic Area, Animal Type, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Category, Therapeutic Area, Animal Type, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Idexx Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer Animal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck Animal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VetMed Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim Animal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechra Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Veterinary Laboratories Agency
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Triveritas
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PetDx
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Animal Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Spectrum Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Animal Health International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Animal Metabolomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations